These NPs are in situ capped with GSH, a biocompatible molecule with amino and carboxylic terminal groups for subsequent crosslinking processes [37,38,39]
Forme bio-identique aux tissus de l'organisme
Germany GLP-1 Drugs Market Trends The use of GLP-1 drugs in Germany is increasing due to growing incidences of type 2 diabetes as well as obesity
Non-viral vectors for gene-based therapy
:max_bytes(150000):strip_icc()/VWH-GettyImages-2158519129-372ed708fbbb4c6e9f472a8218cd52ee.jpg)
Technical Information Compound Name: Melanotan II (MT-II) Chemical Classification: Synthetic Melanocortin Receptor Agonist Peptide Composition Melanotan II (MT-II) is a synthetic peptide analogue structurally related to -melanocyte-stimulating hormone (-MSH) and is commonly researched for its potential interaction with: Melanogenesis pathways Pigmentation-related signaling Melanocortin receptor activity Neuroendocrine mechanisms Peptide Characteristics Synthetic melanocortin receptor agonist peptide Pigmentation and melanogenesis research peptide Commonly researched for melanin-production and UV-response pathways Investigated for appetite-related and neuroendocrine signaling Frequently studied in behavioral-response and melanocortin-system research models Amino Acid Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH Molecular Formula: CHNO Molecular Weight: 1024.2 g/mol Appearance: White to off-white lyophilized powder Solubility: Water soluble Research Category: Melanocortin, pigmentation, and neuroendocrine research peptide Common Research Areas Pigmentation and melanogenesis research UV-response and pigmentation-adaptation studies Melanocortin receptor signaling investigations Appetite-related neuroregulatory pathways Behavioral-response and neuroendocrine research Central nervous system melanocortin studies Stability Melanotan II is typically supplied in lyophilized form to support peptide stability, purity, and long-term storage integrity during laboratory handling and research use

kr/kvm r det genomsnittliga kvadratmeterpriset fr bostadsrtter i Sverige, senaste 12 mn